logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Top education offered at half price

7 February 2012

A Dubai based company (GEMS Education) plans to set up fee paying schools for boys and girls aged 3-18 across England over the next two years. Exact locations have not yet been confirmed but they aim to target areas with fewer private schools.

The company will undercut private schools fees that are around £16,000 per year by offering parents an opportunity to send their children to a private school at a cheaper annual price of £8,000 to £12,000. By offering the same standard of education and facilities such as on site doctors, they aim to attract parents struggling to pay the usual private school fees in the current economic climate.

The schools will be subject to the same standards and inspection process that applies to other independent schools in England. However, there is concern as to where and how these savings will be made and concern that the high standards associated with the independent school sector could be diluted by this venture.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up